Literature DB >> 21384534

Epigenetic control of embryonic renal cell differentiation by L1 retrotransposon.

Kenneth S Ramos1, Diego E Montoya-Durango, Ivo Teneng, Adrian Nanez, Vilius Stribinskis.   

Abstract

BACKGROUND: L1 retroelements may play a central role in morphogenesis through epigenetic mechanisms involving recruitment of chromatin modifying protein complexes. Retroelements are repressed in terminally differentiated cells, and highly active in embryonic, undifferentiated, and transformed cells. It is not clear if the modulation of differentiation by L1 is a "cause" or "effect". The purpose of this study was to determine if murine embryonic kidney cells of clonal origin (mK4 cells) harbor retrotransposition events upon ectopic expression of L1, and the impact of L1 on embryonic kidney cell differentiation. Given that L1 is reactivated by aryl hydrocarbon receptor (AHR) ligands, we also sought to investigate the effects of benzo(a)pyrene (BaP) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the genetic network of mK4 cells.
METHODS: The mK4 cells overexpressing human L1(RP) were assessed for changes in proliferation and expression of molecular markers of cellular differentiation.
RESULTS: L1(RP) increased proliferation rates and markedly downregulated differentiation programming in mK4 cells. These genetic alterations were recapitulated by exogenous activation of L1 by AHR ligands.
CONCLUSION: L1 regulates nephrogenesis in vitro via both insertional and non-insertional mechanisms that disrupt mesenchymal to epithelial transition. Thus, a feedback loop involving L1, WT1, and AHR may play a role in regulation of kidney morphogenesis. Birth Defects Research (Part A), 2011. © 2011 Wiley-Liss, Inc.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21384534      PMCID: PMC3180906          DOI: 10.1002/bdra.20786

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  56 in total

Review 1.  The establishment of Spemann's organizer and patterning of the vertebrate embryo.

Authors:  E M De Robertis; J Larraín; M Oelgeschläger; O Wessely
Journal:  Nat Rev Genet       Date:  2000-12       Impact factor: 53.242

Review 2.  Branching morphogenesis during kidney development.

Authors:  M Pohl; R O Stuart; H Sakurai; S K Nigam
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

3.  Demethylation of the zygotic paternal genome.

Authors:  W Mayer; A Niveleau; J Walter; R Fundele; T Haaf
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

Review 4.  Morphogen gradient interpretation.

Authors:  J B Gurdon; P Y Bourillot
Journal:  Nature       Date:  2001-10-25       Impact factor: 49.962

5.  Microarray analysis of novel cell lines representing two stages of metanephric mesenchyme differentiation.

Authors:  M Todd Valerius; Larry T Patterson; David P Witte; S Steven Potter
Journal:  Mech Dev       Date:  2002-03       Impact factor: 1.882

6.  Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice.

Authors:  G P Lahvis; S L Lindell; R S Thomas; R S McCuskey; C Murphy; E Glover; M Bentz; J Southard; C A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 7.  Chromatin modification and epigenetic reprogramming in mammalian development.

Authors:  En Li
Journal:  Nat Rev Genet       Date:  2002-09       Impact factor: 53.242

8.  Quantitative study of the comma-shaped body, S-shaped body and vascularized glomerulus in the second and third human gestational trimesters.

Authors:  Jorge Reis Almeida; Carlos Alberto Mandarim-de-Lacerda
Journal:  Early Hum Dev       Date:  2002-10       Impact factor: 2.079

9.  Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation.

Authors:  Ivo Teneng; Diego E Montoya-Durango; James L Quertermous; Mary E Lacy; Kenneth S Ramos
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

10.  Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues.

Authors:  P Medstrand; J Blomberg
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more
  7 in total

1.  Reprogramming of the HepG2 genome by long interspersed nuclear element-1.

Authors:  Pasano Bojang; Ruth A Roberts; Mark J Anderton; Kenneth S Ramos
Journal:  Mol Oncol       Date:  2013-04-17       Impact factor: 6.603

2.  AHR regulates WT1 genetic programming during murine nephrogenesis.

Authors:  M Hadi Falahatpisheh; Adrian Nanez; Kenneth S Ramos
Journal:  Mol Med       Date:  2011-08-18       Impact factor: 6.354

3.  Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.

Authors:  Jing Tian; Soo Ok Lee; Liang Liang; Jie Luo; Chiung-Kuei Huang; Lei Li; Yuanjie Niu; Chawnshang Chang
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

Review 4.  Role of long interspersed nuclear element-1 in the regulation of chromatin landscapes and genome dynamics.

Authors:  Kenneth S Ramos; Pasano Bojang; Emma Bowers
Journal:  Exp Biol Med (Maywood)       Date:  2021-07-25

Review 5.  New Trends in Aryl Hydrocarbon Receptor Biology.

Authors:  Sonia Mulero-Navarro; Pedro M Fernandez-Salguero
Journal:  Front Cell Dev Biol       Date:  2016-05-11

6.  Epigenetic reactivation of LINE-1 retrotransposon disrupts NuRD corepressor functions and induces oncogenic transformation in human bronchial epithelial cells.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  Mol Oncol       Date:  2018-06-21       Impact factor: 6.603

7.  Comprehensive analysis based on DNA methylation and RNA-seq reveals hypermethylation of the up-regulated WT1 gene with potential mechanisms in PAM50 subtypes of breast cancer.

Authors:  Chongyang Ren; Xiaojiang Tang; Haitao Lan
Journal:  PeerJ       Date:  2021-05-04       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.